We've found
620
archived clinical trials in
ADHD
We've found
620
archived clinical trials in
ADHD
Evaluation of SPN-812 ER Low Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 100 and 200 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Evaluation of SPN-812 ER Low Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 100 and 200 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of SPN-812 ER Low Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 100 and 200 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Evaluation of SPN-812 ER Low Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 100 and 200 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of SPN-812 ER Low Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 100 and 200 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Evaluation of SPN-812 ER Low Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 100 and 200 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of SPN-812 ER High Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Evaluation of SPN-812 ER High Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of SPN-812 ER High Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Evaluation of SPN-812 ER High Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of SPN-812 ER High Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Evaluation of SPN-812 ER High Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of SPN-812 ER High Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Evaluation of SPN-812 ER High Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of SPN-812 ER High Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Evaluation of SPN-812 ER High Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of SPN-812 ER High Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Evaluation of SPN-812 ER High Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of SPN-812 ER High Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Evaluation of SPN-812 ER High Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of SPN-812 ER High Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Evaluation of SPN-812 ER High Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of SPN-812 ER High Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Evaluation of SPN-812 ER High Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of SPN-812 ER High Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Evaluation of SPN-812 ER High Dose in Children With ADHD
Updated: 12/31/1969
Evaluation of SPN 812 ER 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Four-week Open-trial Extension TNS for ADHD
Updated: 12/31/1969
Four-week Open-trial Extension Study of Trigeminal Nerve Stimulation (TNS) for Youth Previously Randomized to Sham in a Double-Blind Trial
Status: Enrolling
Updated: 12/31/1969
Four-week Open-trial Extension TNS for ADHD
Updated: 12/31/1969
Four-week Open-trial Extension Study of Trigeminal Nerve Stimulation (TNS) for Youth Previously Randomized to Sham in a Double-Blind Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
12 Month Open Extension of TNS for ADHD.
Updated: 12/31/1969
12 Month Open Extension Study of TNS for ADHD .
Status: Enrolling
Updated: 12/31/1969
12 Month Open Extension of TNS for ADHD.
Updated: 12/31/1969
12 Month Open Extension Study of TNS for ADHD .
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
HealthSpark: Health Access for Children in Federally-Subsidized Child Care
Status: Enrolling
Updated: 9/7/2006
Updated: 9/7/2006
HealthSpark: Health Access for Children in Federally-Subsidized Child Care
Status: Enrolling
Updated: 9/7/2006
Updated: 9/7/2006
Click here to add this to my saved trials
An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Updated: 10/29/2009
An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 10/29/2009
An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Updated: 10/29/2009
An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 10/29/2009
Click here to add this to my saved trials
Effects of Cognitive Training on Academic Task Performance in Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 5/13/2010
Pilot Testing of Cognitive Training on Academic Task Performance in Children With Attention-deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 5/13/2010
Effects of Cognitive Training on Academic Task Performance in Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 5/13/2010
Pilot Testing of Cognitive Training on Academic Task Performance in Children With Attention-deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 5/13/2010
Click here to add this to my saved trials
Combined Cognitive Remediation and Behavioral Intervention for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)
Updated: 6/3/2010
Combined Cognitive Remediation and Behavioral Intervention for Treatment of ADHD
Status: Enrolling
Updated: 6/3/2010
Combined Cognitive Remediation and Behavioral Intervention for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)
Updated: 6/3/2010
Combined Cognitive Remediation and Behavioral Intervention for Treatment of ADHD
Status: Enrolling
Updated: 6/3/2010
Click here to add this to my saved trials
Pilot Study of Shared Care of ADHD in a Pediatric Clinic:Colocation of a Psychologist as an ADHD Care Manager
Updated: 11/4/2010
Pilot Study of Shared Care of ADHD in a Pediatric Clinic:Colocation of a Psychologist as an ADHD Care Manager
Status: Enrolling
Updated: 11/4/2010
Pilot Study of Shared Care of ADHD in a Pediatric Clinic:Colocation of a Psychologist as an ADHD Care Manager
Updated: 11/4/2010
Pilot Study of Shared Care of ADHD in a Pediatric Clinic:Colocation of a Psychologist as an ADHD Care Manager
Status: Enrolling
Updated: 11/4/2010
Click here to add this to my saved trials
Pilot Study of Shared Care of ADHD in a Pediatric Clinic:Colocation of a Psychologist as an ADHD Care Manager
Updated: 11/4/2010
Pilot Study of Shared Care of ADHD in a Pediatric Clinic:Colocation of a Psychologist as an ADHD Care Manager
Status: Enrolling
Updated: 11/4/2010
Pilot Study of Shared Care of ADHD in a Pediatric Clinic:Colocation of a Psychologist as an ADHD Care Manager
Updated: 11/4/2010
Pilot Study of Shared Care of ADHD in a Pediatric Clinic:Colocation of a Psychologist as an ADHD Care Manager
Status: Enrolling
Updated: 11/4/2010
Click here to add this to my saved trials
Risk of Attention Deficit Hyperactivity Disorder (ADHD) in the Children of Adults With ADHD Not Otherwise Specified (NOS)
Updated: 7/12/2011
Risk of Attention Deficit Hyperactivity Disorder in the Children of Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified: A Pilot Study
Status: Enrolling
Updated: 7/12/2011
Risk of Attention Deficit Hyperactivity Disorder (ADHD) in the Children of Adults With ADHD Not Otherwise Specified (NOS)
Updated: 7/12/2011
Risk of Attention Deficit Hyperactivity Disorder in the Children of Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified: A Pilot Study
Status: Enrolling
Updated: 7/12/2011
Click here to add this to my saved trials
Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?
Updated: 4/9/2012
Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?
Status: Enrolling
Updated: 4/9/2012
Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?
Updated: 4/9/2012
Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?
Status: Enrolling
Updated: 4/9/2012
Click here to add this to my saved trials
Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?
Updated: 4/9/2012
Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?
Status: Enrolling
Updated: 4/9/2012
Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?
Updated: 4/9/2012
Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?
Status: Enrolling
Updated: 4/9/2012
Click here to add this to my saved trials
Vascular Effects of Attention Deficit Hyperactivity Disorder (ADHD) Medications in Youth
Updated: 10/22/2012
Vascular Consequences of ADHD Medication Use in Children and Adolescents
Status: Enrolling
Updated: 10/22/2012
Vascular Effects of Attention Deficit Hyperactivity Disorder (ADHD) Medications in Youth
Updated: 10/22/2012
Vascular Consequences of ADHD Medication Use in Children and Adolescents
Status: Enrolling
Updated: 10/22/2012
Click here to add this to my saved trials
Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study
Updated: 10/30/2012
Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study
Status: Enrolling
Updated: 10/30/2012
Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study
Updated: 10/30/2012
Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study
Status: Enrolling
Updated: 10/30/2012
Click here to add this to my saved trials
Time Course of Response to Methylphenidate HCl ER Capsules in Children 6 to 12 Years With ADHD in Classroom Setting
Updated: 1/22/2013
A Randomized, Double-Blind Study of the Time Course of Response to Biphentin Methylphenidate Hydrochloride ER Capsules Compared to Placebo in Children 6 to 12 Years With Attention Deficit Hyperactivity Disorder in Analog Classroom Setting
Status: Enrolling
Updated: 1/22/2013
Time Course of Response to Methylphenidate HCl ER Capsules in Children 6 to 12 Years With ADHD in Classroom Setting
Updated: 1/22/2013
A Randomized, Double-Blind Study of the Time Course of Response to Biphentin Methylphenidate Hydrochloride ER Capsules Compared to Placebo in Children 6 to 12 Years With Attention Deficit Hyperactivity Disorder in Analog Classroom Setting
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Updated: 1/22/2013
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/22/2013
Click here to add this to my saved trials
TD-9855 Mass Balance Study
Updated: 8/15/2013
An Open-Label Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion of TD-9855 Following a Single Oral Dose Containing Approximately 100 µCi [14C]-Labeled TD-9855 (20 mg) in Healthy Subjects
Status: Enrolling
Updated: 8/15/2013
TD-9855 Mass Balance Study
Updated: 8/15/2013
An Open-Label Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion of TD-9855 Following a Single Oral Dose Containing Approximately 100 µCi [14C]-Labeled TD-9855 (20 mg) in Healthy Subjects
Status: Enrolling
Updated: 8/15/2013
Click here to add this to my saved trials
Integrative Coping Group for Children
Updated: 4/21/2014
Treatment of Psychosomatic Pain in Youth (ToPSY): A Pilot Study
Status: Enrolling
Updated: 4/21/2014
Integrative Coping Group for Children
Updated: 4/21/2014
Treatment of Psychosomatic Pain in Youth (ToPSY): A Pilot Study
Status: Enrolling
Updated: 4/21/2014
Click here to add this to my saved trials
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
Updated: 4/27/2014
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
Updated: 4/27/2014
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
Click here to add this to my saved trials
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
Updated: 4/27/2014
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
Updated: 4/27/2014
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
Click here to add this to my saved trials
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
Updated: 4/27/2014
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
Updated: 4/27/2014
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
Click here to add this to my saved trials
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
Updated: 4/27/2014
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
Updated: 4/27/2014
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
Click here to add this to my saved trials
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
Updated: 4/27/2014
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )
Updated: 4/27/2014
A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/27/2014
Click here to add this to my saved trials